Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             111 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Meta-proteogenomic Approach to Peptide Identification Incorporating Assembly Uncertainty and Genomic Variation* Li, Sujun

8S1 p. S183-S192
artikel
2 An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation* Arshad, Osama A.

8S1 p. S26-S36
artikel
3 Author Index
8S1 p. v
artikel
4 Author Index
8S1 p. S389-S412
artikel
5 Author Index
8S1 p. S68-S70
artikel
6 Calendar
8S1 p. S413-S414
artikel
7 Calendar
8S1 p. S71-S72
artikel
8 Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer* Zhan, Xiaohui

8S1 p. S37-S51
artikel
9 Editorial Board
8S1 p. i-ii
artikel
10 Editorial Board
8S1 p. i-ii
artikel
11 Editorial Board
8S1 p. i-ii
artikel
12 Editorial Board
8S1 p. i-ii
artikel
13 Editorial Board
8S1 p. i-ii
artikel
14 Editorial Board
8S1 p. i-ii
artikel
15 Exploiting Interdata Relationships in Next-generation Proteomics Analysis* Vitrinel, Burcu

8S1 p. S5-S14
artikel
16 Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis* Liu, Wenke

8S1 p. S169-S182
artikel
17 Graph Algorithms for Condensing and Consolidating Gene Set Analysis Results* Savage, Sara R.

8S1 p. S141-S152
artikel
18 Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics* Federspiel, Joel D.

8S1 p. S92-S113
artikel
19 Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis* Song, Xiaoyu

8S1 p. S52-S65
artikel
20 Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors* Ma, Weiping

8S1 p. S66-S81
artikel
21 Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications* Brademan, Dain R.

8S1 p. S193-S201
artikel
22 metaQuantome: An Integrated, Quantitative Metaproteomics Approach Reveals Connections Between Taxonomy and Protein Function in Complex Microbiomes* Easterly, Caleb W.

8S1 p. S82-S91
artikel
23 Mini Symposium
8S1 p. S11-S13
artikel
24 Mini Symposium
8S1 p. S14-S17
artikel
25 Mini Symposium
8S1 p. S13-S16
artikel
26 MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data* Meng, Chen

8S1 p. S153-S168
artikel
27 Multi-omics Characterization of Interaction-mediated Control of Human Protein Abundance levels* Sousa, Abel

8S1 p. S114-S125
artikel
28 Poster Session A
8S1 p. S18-S25
artikel
29 Poster Session A
8S1 p. S21-S33
artikel
30 Poster Session A
8S1 p. S21-S38
artikel
31 Poster Session A
8S1 p. S19-S27
artikel
32 Poster Session B
8S1 p. S31-S39
artikel
33 Poster Session B
8S1 p. S38-S50
artikel
34 Poster Session B
8S1 p. S43-S60
artikel
35 Poster Session B
8S1 p. S33-S40
artikel
36 Poster Session C
8S1 p. S44-S52
artikel
37 Poster Session C
8S1 p. S53-S64
artikel
38 Poster Session C
8S1 p. S44-S52
artikel
39 Program
8S1 p. S1-S10
artikel
40 Program
8S1 p. S1-S10
artikel
41 Program
8S1 p. S1-S11
artikel
42 PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms* Verbruggen, Steven

8S1 p. S126-S140
artikel
43 Proteomics Is Not an Island: Multi-omics Integration Is the Key to Understanding Biological Systems* Zhang, Bing

8S1 p. S1-S4
artikel
44 Reproducibility and Transparency by Design* Petyuk, Vladislav A.

8S1 p. S202-S204
artikel
45 Revised Draft Guidelines for Proteomic Data Publication
8S1 p. ix-xi
artikel
46 Session 4
8S1 p. S29-S30
artikel
47 Session 5
8S1 p. S40-S41
artikel
48 Session 2
8S1 p. S16-S17
artikel
49 Session 1
8S1 p. S14-S15
artikel
50 Session 6
8S1 p. S42-S43
artikel
51 Session 8
8S1 p. S55-S56
artikel
52 Session 3
8S1 p. S26-S28
artikel
53 Session 7
8S1 p. S53-S54
artikel
54 Session 2
8S1 p. S20
artikel
55 Session 4
8S1 p. S37
artikel
56 Session 7
8S1 p. S65-S66
artikel
57 Session 8
8S1 p. S67
artikel
58 Session 1
8S1 p. S18-S19
artikel
59 Session 6
8S1 p. S52
artikel
60 Session 3
8S1 p. S34-S36
artikel
61 Session 5
8S1 p. S51
artikel
62 Session 2
8S1 p. S39-S42
artikel
63 Session 1
8S1 p. S17-S20
artikel
64 Session 3
8S1 p. S41-S43
artikel
65 Session 1
8S1 p. S11-S18
artikel
66 Session 2
8S1 p. S28-S32
artikel
67 Session 4
8S1 p. S65-S68
artikel
68 Session 3
8S1 p. S61-S64
artikel
69 Session 4
8S1 p. S53-S56
artikel
70 Session 2: Bioinformatics
8S1 p. S17-S34
artikel
71 Session 3: Functional Proteomics-Cell Signaling
8S1 p. S35-S43
artikel
72 Session 4: Functional Proteomics-Protein-Protein Interactions and Networks
8S1 p. S44-S59
artikel
73 Session 5: HUPO Initiatives-Antibodies
8S1 p. S60-S67
artikel
74 Session 6: HUPO Initiatives-Brain
8S1 p. S68-S73
artikel
75 Session 7: HUPO Initiatives-Glycoproteomics
8S1 p. S74-S76
artikel
76 Session 8: HUPO Initiatives-Liver
8S1 p. S77-S80
artikel
77 Session 9: HUPO Initiatives-New Technologies
8S1 p. S81-S84
artikel
78 Session 10: HUPO Initiatives-Plasma
8S1 p. S85-S87
artikel
79 Session 11: HUPO Initiatives-Standards
8S1 p. S88
artikel
80 Session 41: Industry Sponsored Symposia
8S1 p. S387-S388
artikel
81 Session 1: Invited Speaker Abstracts
8S1 p. S1-S16
artikel
82 Session 13: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Cancer Proteomics
8S1 p. S98-S139
artikel
83 Session 14: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Clinical Biomarker Discovery
8S1 p. S140-S169
artikel
84 Session 15: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Heart & Stroke
8S1 p. S170-S176
artikel
85 Session 16: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Liver
8S1 p. S177-S182
artikel
86 Session 17: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Neuroproteomics
8S1 p. S183-S196
artikel
87 Session 18: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Obesity & Diabetes
8S1 p. S197-S200
artikel
88 Session 23: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other
8S1 p. S226-S232
artikel
89 Session 19: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Other Tissues
8S1 p. S201-S209
artikel
90 Session 20: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Plasma
8S1 p. S210-S215
artikel
91 Session 21: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Target Identification and Validation
8S1 p. S216-S219
artikel
92 Session 22: Medical, Clinical, Pharmaceutical, and Disease Proteomics-Toxicology
8S1 p. S220-S225
artikel
93 Session 24: Model Organisms-Microbial Proteomes
8S1 p. S233-S251
artikel
94 Session 25: Model Organisms-Other Non-Mammalian Proteomes
8S1 p. S252-S255
artikel
95 Session 26: Model Organisms-Plant Proteomes
8S1 p. S256-S261
artikel
96 Session 39: News Corner
8S1 p. S360-S382
artikel
97 Session 12: Organellar Proteomics
8S1 p. S89-S97
artikel
98 Session 40: Other
8S1 p. S383-S386
artikel
99 Session 27: Post-Translational Modifications-Glycosylation and Glycoproteomics
8S1 p. S262-S267
artikel
100 Session 28: Post-Translational Modifications-Other Post-Translational Modifications
8S1 p. S268-S272
artikel
101 Session 29: Post-Translational Modifications-Phosphorylation and Phosphoproteomics
8S1 p. S273-S284
artikel
102 Session 30: Proteomics in Biotechnology
8S1 p. S285-S289
artikel
103 Session 31: Proteomics Technologies-2D Electrophoresis
8S1 p. S290-S298
artikel
104 Session 33: Proteomics Technologies-Mass Spectrometry-based Quantitative Proteomics
8S1 p. S314-S329
artikel
105 Session 32: Proteomics Technologies-Mass Spectrometry Technology
8S1 p. S299-S313
artikel
106 Session 34: Proteomics Technologies-Nanotechnology/Protein Arrays
8S1 p. S330-S338
artikel
107 Session 37: Proteomics Technologies-Other
8S1 p. S351-S357
artikel
108 Session 36: Proteomics Technologies-Protein Chemistry
8S1 p. S348-S350
artikel
109 Session 35: Proteomics Technologies-Protein Prefractionation Technologies
8S1 p. S339-S347
artikel
110 Session 38: Structural Proteomics
8S1 p. S358-S359
artikel
111 TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data* Chen, Mei-Ju May

8S1 p. S15-S25
artikel
                             111 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland